DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir Sulfate) - Current Clinical Trials

 
 



Reyataz Related Clinical Trials

Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat [Completed]

Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects [Completed]

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants [Completed]

Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection [Completed]

Phase IIB Pilot of Atazanavir + Raltegravir [Terminated]

Metabolic Effects of Switching Kaletra to Boosted Reyataz [Completed]

Raltegravir and Atazanavir Dosing Strategy Study [Completed]

GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir [Completed]

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study [Active, not recruiting]

The Effects of Atazanavir-induced Hyperbilirubinemia During Human Endotoxemia [Completed]

Atazanavir Twice Daily [Completed]

Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone [Completed]

Effects of Gastric pH on the Pharmacokinetics of Atazanavir [Completed]

Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts [Recruiting]

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients [Completed]

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens [Active, not recruiting]

Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression [Active, not recruiting]

Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Reyataz [Completed]

Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study [Completed]

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients [Completed]

Drug Interaction Study With Proton Pump Inhibitor [Completed]

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Completed]

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) [Completed]

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects [Completed]

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females [Completed]

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment [Completed]

ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir [Active, not recruiting]

ATV/Ritonavir Nevirapine Interaction (USPAC) [Completed]

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women [Completed]

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome [Completed]

Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers [Not yet recruiting]

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV [Completed]

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study [Completed]

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir [Recruiting]

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access [Active, not recruiting]

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir [Completed]

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression [Terminated]

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Completed]

Switch to Unboosted Atazanavir With Tenofovir Study [Active, not recruiting]

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients [Terminated]

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. [Completed]

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients [Completed]

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients [Completed]

Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir [Recruiting]

"The Once A Day Protease Inhibitor Regimens" [Completed]

Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression [Completed]

Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population [Completed]

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) [Completed]

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada [Completed]

A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults [Completed]

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study [Completed]

Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction [Completed]

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2) [Active, not recruiting]

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients [Completed]

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients [Not yet recruiting]

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients [Terminated]

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Completed]

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir [Withdrawn]

Raltegravir vs. Atazanavir in Combination With Truvada� for the Treatment of Antiretroviral na�ve HIV Infected Patients [Completed]

Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia [Completed]

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults [Completed]

Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression [Active, not recruiting]

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients [Completed]

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors [Completed]

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy [Completed]

Korean Post-marketing Surveillance for Reyataz [Recruiting]

Bioequivalence Study of Atazanavir 300 mg Capsule [Completed]

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) [Completed]

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Completed]

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe [Completed]

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Recruiting]

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients [Completed]

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients [Recruiting]

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV [Completed]

A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir [Completed]

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [Completed]

Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir [Completed]

Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults [Completed]

Drug Interaction Study [Completed]

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV [Completed]

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [Terminated]

A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers [Completed]

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women (WAVES) [Active, not recruiting]

Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects [Recruiting]

Pilot Study of a Raltegravir Based NRTI Sparing Regimen [Completed]

Taste Properties of Atazanavir and Cobicistat [Recruiting]

Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir [Completed]

DDI HV (ATV - Merck) [Completed]

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy [Completed]

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen [Completed]

Study to Evaluate a HIV Drug for the Treatment of HIV Infection [Completed]

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Completed]

Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015